PsychiatricTimes Members: Login | Register

|     

PsychiatricTimes SearchMedica Medline Drugs

Powered by SearchMedica

 
Risk Assessment
News
Current Issues
Blogs
Special Reports
CME
Conferences
Resources
Careers
Multimedia
About Us
 

Home » Blogs » Couch in Crisis

Psychiatric Times.
 

Polypharmacy, PTSD, and Accidental Death From Prescription Medication

By Allen Frances, MD | March 9, 2011

The New York Times of February 14 carries the disturbing news of an alarming increase in deaths from accidental overdose among our active duty military personnel and our war veterans. The usual scenario is a diagnosis of PTSD (often accompanied by a pain syndrome) unsuccessfully treated with a wide array of psychotropic drugs, which in their aggregate wind up killing the patient-- often at a very young age. Autopsy reveals significant blood levels of prescribed medication reflecting the heavy drug cocktail and no other apparent cause of death.
  
PTSD/pain patients are often prescribed a combination of psychotropics that may include--one antidepressant, one antipsychotic, one antianxiety, one sleep, and one pain medicine. Sometimes, the enormous medication burden is worsened even further--either by the simultaneous prescription of more than one drug from a given class or the additional self medication effected by the sharing of pills among patients.

Individual psychotropic drugs can have serious side effects--in excessive combination they sometimes threaten respiratory and cardiac function in a potentially lethal way. And the whole is even more dangerous than the sum of its parts since the medications can interact to increase each other's blood levels. Prescription drugs are overtaking illegal drugs as the primary cause of accidental overdose and death.  

To its credit, the military is catching on and beginning to initiate procedures to restrict and review heedless and excessive polypharmacy. But this is a tough problem with no ready solutions. Some of the factors involved are:
1. The over prescription of multiple drugs that is also rampant in civilian life. There is no research literature to guide and restrain polypharmacy--so it becomes subject to individual physician whim, often under patient pressure for relief.
2. PTSD has no effective medication  treatment, encouraging the potentially dangerous scatter shot approach of treating the individual symptoms each individually with its own medication.
3.The recent ubiquity and carelessness of prescription of dangerous pain medications that resulted as an  over-compensation by the military after it was previously criticized for being too sparing in their use.
4. Because they are legal, accessible, and cheap, pain medications are now an attractive alternative to illegal recreational drug use--but with dangerous consequences given their interaction with other psychotropic drugs. 
5.The tendency to always add and never sunset medications leads to the continued use of drugs that have not been effective, but will add on to the cumulative and interacting side effects.
6. Chasing the side effects of one drug by adding another to deal with them--eg if an antidepressant causes anxiety or insomnia it is usually a mistake to add yet another potentially harmful pill to deal with these side effects rather than reducing the dose or trying another antidepressant.
7. A shortage of mental health personnel that results in pill pushing rather than the easy access to the one treatment with clear efficacy for PTSD- cognitive behavior therapy.  
8. Forgetting,the Hippocratic injunction of "FIRST DO NO HARM." This evolved in ancient Greece specifically to discourage practitioners from being overly aggressive in using dangerous treatments for conditions that are not responding (and may not respond well) to existing interventions. It is important to recognize that sometimes the treatment becomes worse than the disease. This is exactly our modern dilemma with some cases of PTSD where restraint is safer and saner than unreasonable treatment perfectionism and optimism-- which can be costly and sometimes even lethal.

None of these problems will be easy to solve, but some immediate corrective steps seem obvious:
1. Greatly enhance the availability of CBT. If it is too expensive or difficult to recruit trained mental health professionals, train the needed cohort of medics and paraprofessionals. CBT is readily teachable to those with limited previous training.
2. Educate doctors on the risks and limitations of polypharmacy for both PTSD and for pain syndromes, and especially the combination of both.
3. Require special explanations from physicians whenever they prescribe more than three psychotropic medications, or prescribe higher than standard dosages, or prescribe drugs that have significant interactions, or prescribe simultaneously two drugs from the same class.  
4. Require automatic, thorough quality assurance auditing to ensure there are adequate reasons for exceptions.
5. Pharmacies should routinely use available drug interaction algorithms to spot dangerous doses and drug combinations and to alert clinicians.  
6. Readily available detoxification and rehabilitation should be provided for those who have become addicted to prescription medications and/or other addictive substances.

This problem of prescription overdose in the military has its parallel in civilian life. The tragic overdose victims in both spheres represent  canaries in the coal mine--only the most obvious victims of what has become our national orgy of over using psychotropic drugs.

 

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

  • Oldest First
  • Newest First

by Eric Michael Brown | March 18, 2011 12:59 PM EDT

I agree with just about everything that Dr. Frances says here.  I would like to clarify one point, however.  When Dr. Frances says there is no effective pharmacotherapy for PTSD, and similarly that CBT is the only treatment that has been shown effective for PTSD, I think he is (mis)quoting the Institute of Medicine review of the evidence for PTSD treatments published in 2008.  That review found that the quality of evidence supporting pharmacotherapy for PTSD, and for all psychotherapies aside from Prolonged Exposure therapy for PTSD, did not meet the rigorous standards the panel set.  It is a too-common mistake to assert that lack of evidence means lack of efficacy, and I'm surprised that someone as astute as Dr. Frances has made this basic mistake. 

What we have in the area of PTSD treatment is a lack of evidence of high quality and reliability for most of the commonly used therapies.  This most emphatically does not mean that pharmacotherapy or therapies other than PE are ineffective, it simply means we can't come to a confident conclusion either way.   Put another way, it is not possible to say either "medications are effective for PTSD"or "PTSD has no effective medication  treatment" with a high degree of certainty.  Dr. Frances has done the latter, which worries me.  Those of us who treat a lot of patients with PTSD still have an obligation to try to help our patients in the best and safest way we can, and until we have evidence of the highest quality, we must fall back on the evidence we have, using a large dose of clinical judgment mixed in.  I hope that Dr. Frances's statement here does not have the unintended consequence of causing either patients or practitioners to give up on treatments that might make a positive difference for some individuals.

 

Eric Brown MD

by Yvonne Barash | March 18, 2011 10:53 AM EDT

I'm wondering, after reading #2, "PTSD has no effective medication treatment," then why are Paxil and Zoloft both FDA approved for treating it?  Also, the anecdotal Prazosin for insomnia/nightmares (though with that one you've got to be careful of hypotension, as it was originally developed as an antihypertensive).

by Ann-Marie Anderson | March 10, 2011 2:09 PM EST

Dr Francis,

This is a very thought-provoking article. Having provided psychiatric services in the military I understand the concerns regarding polypharmacy.  It is true that CBT, EMDR and prolonged exposure are effective non-pharmacological means of treating PTSD. However, many patients that I have encountered either want immediate results or have chronic difficulty dealing with symptoms such as passive suicidality, nightmares, anxiety, irritability and primarily isomnia while participating in a CBT-based program. Hence, they are often referred to prescribers for concurrent psychopharmacotherapy.

Trying to treat these symptoms in the absence of a commitment to engage in psychotherapy (not just attending therapy) is like trying to shoot at a moving target. It is even worse if  you were a poor shot from the start.  As a result many providers will exhaust all the medications in their pharmacological arsenal in an effort to appease some of  patients. Unfortunately, I have seen where it results in significant polypharmacy just to keep the patient stabililized.

Of course, this does not mean that more accountability, acknowledgement and explanation is not required.  Teaching paraprofessionals such as medics to identify and treat PTSD may be one of the answers, but will they be able to recognize their limitations? Will they be able to recognize when the intervention of a psychopharmacologist is necessary? 

A.Anderson






 
TOPIC INDEX

Addiction Medicine
Alzheimer Disease
Anxiety Disorders
ADHD
Bipolar Disorder
Child & Adolescent Psychiatry
Dementia
Depression
DSM-5
Geriatric Psychiatry

 

Health Care Reform
Major Depressive
Disorder
OCD
Personality Disorders
Schizoaffective Disorder
Schizophrenia
Sleep Disorders
Somatoform Disorders
All Topics

 


 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Developmental Psychopathology Comes of Age
  • The Moral Struggles of Practicing Psychiatrists
  • Grief and Depression: The Sages Knew the Difference
  • Update on Mental Health Benefits and Substance Use Disorder Services Under the Affordable Care Act
  • Synthetic Cathinones: Signs, Symptoms, and Treatment
  • Grief and Depression: The Sages Knew the Difference
  • Successful Aging: Strategies to Help Maintain and Nurture a Healthy Brain
  • Synthetic Cathinones: Signs, Symptoms, and Treatment
  • Developmental Psychopathology Comes of Age
  • Psychiatry and the Myth of “Medicalization”
  • Experts Discuss Changes, Updates in DSM-5
  • The Paradox of Choice: When More Medications Mean Less Treatment
  • Will Your Clinical Records Support You in Court?
  • Refinements in ECT Techniques
  • Successful Aging: Strategies to Help Maintain and Nurture a Healthy Brain
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • Grief and Depression: The Sages Knew the Difference
  • Psychiatry and the Myth of “Medicalization”
  • Is it Time for a Treatment Manual to Complement DSM-5?
  • NIMH vs DSM 5: No One Wins, Patients Lose
  • DSM-5 Won’t Solve the Overdiagnosis Problem—But Clinicians Can
  • DSM-5 Won’t Solve the Overdiagnosis Problem—But Clinicians Can
  • The Paradox of Choice: When More Medications Mean Less Treatment
  • Experts Discuss Changes, Updates in DSM-5
  • New Insight Into the Neurobiology of Depression
  • Tie One On for Patients
Click here to subscribe to our newsletter


 
CAREER CENTER

  •   Featured Jobs  
  •    Resources   
  • Psychiatry and Nurse Practitioner Opportunities
  • Associate Medical Director - Psychiatrist Delray Beach, Florida
  • Retiring Child Psychiatrist Seeks Replacement August 2010 or Before
  • Chairperson, Dept of Psychiatry Needed
  • FT Staff Psychiatrist - Excellent Benefits
  • BC Adult and Child Psychiatrits - PT and FT Positions Available
  • Managing Risks When Practicing in Three-Party Care Settings
  • 12 Tips for Making Your Practice Greener
  • Keys to Avoiding Malpractice: Standard of Care in Psychiatric Practice
  • Take This Job and Shove It
  • Merging Administrative and Academic Careers in Psychiatry


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy